Interleukin−1 receptor antagonist and heat shock protein 90alfa are independently associated with fatigue and general health in euthyroid Hashimoto’s thyroiditis - Scorecard - MDSpire
Advertisement
Interleukin−1 receptor antagonist and heat shock protein 90alfa are independently associated with fatigue and general health in euthyroid Hashimoto’s thyroiditis
Clinical Scorecard: Independent Associations of Interleukin-1 Receptor Antagonist and Heat Shock Protein 90α with Fatigue and Overall Health in Euthyroid Patients with Hashimoto’s Thyroiditis
At a Glance
Category
Detail
Condition
Hashimoto’s thyroiditis
Key Mechanisms
Interleukin-1 receptor antagonist (IL-1Ra) and heat shock protein 90α (HSP90α) are associated with fatigue and health-related quality of life.
Target Population
Euthyroid patients with Hashimoto’s thyroiditis
Care Setting
Clinical research on autoimmune thyroid disease
Key Highlights
IL-1Ra is independently associated with poorer general health and increased fatigue.
HSP90α shows an inverse association with fatigue, suggesting a protective role.
Anti-TPO antibodies were not significantly associated with patient-reported outcomes.
Guideline-Based Recommendations
Diagnosis
Anti-TPO antibodies are recommended as a key laboratory test in the diagnosis of Hashimoto’s thyroiditis.
Management
Consider immune-mediated mechanisms in managing symptoms of fatigue and HRQOL in euthyroid patients.
Monitoring & Follow-up
Monitor IL-1Ra and HSP90α levels as potential biomarkers for symptom burden.
Risks
Elevated anti-TPO titers may indicate increased symptom burden and reduced HRQOL.
Patient & Prescribing Data
Euthyroid patients with confirmed Hashimoto’s thyroiditis.
Fatigue and HRQOL may remain impaired despite normalization of thyroid hormone levels.
Clinical Best Practices
Evaluate immune-mediated factors in patients with Hashimoto’s thyroiditis experiencing fatigue.
Utilize patient-reported outcomes to assess symptom burden and quality of life.
